BIOREMIA (BIOfilm-REsistant Materials for hard tissue Implant Applications) aims to improve the patient quality of life by minimizing infection rates of medical implants. Implant-related infections caused by bacterial biofilms are a major cause of implant rejection, with high economic and social associated costs. Bacteria growing in biofilm are 100 to 1000 times less susceptible to antimicrobials than planktonic bacteria. Since antibiotic treatments are controversially and ineffective for bacterial biofilm, the best infection control approach is to develop novel preventive measures which specifically focus on the inhibition of both bacterial adhesion and biofilm formation, for instance by acting on the implant material itself. BIOREMIA European Training Network aims to tackle this problem by designing and producing novel knowledge-based biofilm-resistant materials and surfaces aiming to reduce the infection rates of medical implants for bone-related applications (orthopedics and dentistry). Fifteen individual PhD research projects put the biofilm-resistant materials research approach into practice. We train a new generation of young scientists to better integrate research, innovation and social responsibility. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 861046. Find us on Instagram, Twitter and YouTube. Instagram: https://www.instagram.com/bioremia/ Twitter: https://twitter.com/BIOREMIA2 YouTube: https://www.youtube.com/channel/UCeeOFB3mXmIhgiJ0LFyZWbA/featured